Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
Source: itnewsonline.com
📰 Primary Number News
Primary Number News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Primary Number. Real-time updates on events, politics, business and more.
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and...
Source: prnewswire.com
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and...
Source: prnewswire.com
Palacios declares Typhoon Condition I for CNMI
Gov. Arnold I. Palacios, in consultation with the CNMI Homeland Security and Emergency Management Office and the National Weather Service Weather Forecast Office, declared Typhoon Condition I for Saipan, Tinian,
Valerieq Apatang Davidm Apatang Arnoldi Palacios National Weather Service Office Of Homeland Security Rota Health Centers
Source: saipantribune.com
Typhoon Condition 2 declared for Saipan, Tinian; Typhoon Condition 3 maintained for Rota
As of 2pm October 9, 2023, Gov. Arnold I. Palacios, in consultation with the CNMI Homeland Security and Emergency Management and the National Weather Service Guam Weather Forecast Office, has
Arnoldi Palacios Valerieq Apatang Davidm Apatang Koblerville Elementary School Cafeteria Northern Marianas College Office Of The Governor
Source: saipantribune.com
Piramal Pharma Limited Announces Consolidated Results for Q1FY24
/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), today announced its consolidated results for the first quarter (Q1) ended 30th June 2023....
Source: prnewswire.com
Piramal Pharma Limited Announces Consolidated Results for Q1FY24
/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), today announced its consolidated results for the first quarter (Q1) ended 30th June 2023....
Source: prnewswire.com